BACKGROUND/AIMS: The aims of this study were to validate the newly developed version of the Addenbrooke's Cognitive Examination (ACE-III) against standardised neuropsychological tests and its predecessor (ACE-R) in early dementia. METHODS: A total of 61 patients with dementia (frontotemporal dementia, FTD, n = 33, and Alzheimer's disease, AD, n = 28) and 25 controls were included in the study. RESULTS: ACE-III cognitive domains correlated significantly with standardised neuropsychological tests used in the assessment of attention, language, verbal memory and visuospatial function. The ACE-III also compared very favourably with its predecessor, the ACE-R, with similar levels of sensitivity and specificity. CONCLUSION: The results of this study provide objective validation of the ACE-III as a screening tool for cognitive deficits in FTD and AD.
BACKGROUND/AIMS: The aims of this study were to validate the newly developed version of the Addenbrooke's Cognitive Examination (ACE-III) against standardised neuropsychological tests and its predecessor (ACE-R) in early dementia. METHODS: A total of 61 patients with dementia (frontotemporal dementia, FTD, n = 33, and Alzheimer's disease, AD, n = 28) and 25 controls were included in the study. RESULTS: ACE-III cognitive domains correlated significantly with standardised neuropsychological tests used in the assessment of attention, language, verbal memory and visuospatial function. The ACE-III also compared very favourably with its predecessor, the ACE-R, with similar levels of sensitivity and specificity. CONCLUSION: The results of this study provide objective validation of the ACE-III as a screening tool for cognitive deficits in FTD and AD.
Authors: J Caga; S Hsieh; E Highton-Williamson; M C Zoing; E Ramsey; E Devenney; R M Ahmed; M C Kiernan Journal: J Neurol Date: 2017-11-30 Impact factor: 4.849
Authors: Stephanie Wong; Muireann Irish; Eric D Leshikar; Audrey Duarte; Maxime Bertoux; Greg Savage; John R Hodges; Olivier Piguet; Michael Hornberger Journal: Cortex Date: 2016-10-03 Impact factor: 4.027
Authors: Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland Journal: CNS Drugs Date: 2018-07 Impact factor: 5.749
Authors: Belinda R Lennox; Emma C Palmer-Cooper; Thomas Pollak; Jane Hainsworth; Jacqui Marks; Leslie Jacobson; Bethan Lang; Hannah Fox; Berne Ferry; Linda Scoriels; Hannah Crowley; Peter B Jones; Paul J Harrison; Angela Vincent Journal: Lancet Psychiatry Date: 2016-12-08 Impact factor: 27.083
Authors: Zhe Long; Muireann Irish; Olivier Piguet; Matthew C Kiernan; John R Hodges; James R Burrell Journal: J Neurol Date: 2019-02-01 Impact factor: 4.849